Почетна › Мозгове туморске промене › Њујорк › New York City
Kliničke studije za Мозгове туморске промене u gradu New York City, NY
25 studija za Мозгове туморске промене traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Тражи се учесникФаза 2
- Columbia University Irving Medical Center, New York
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Тражи се учесникФаза 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
rTMS for Postoperative Brain Tumor Patients
Тражи се учесник
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Тражи се учесникФаза 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Тражи се учесникФаза 2
- Memorial Sloan-Kettering Cancer Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Тражи се учесникФаза 2
- New York University Langone's Perlmutter Cancer Institute, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- Icahn School of Medicine at Mount Sinai, New York
Chronic CED of TPT for Recurrent Malignant Glioma
Тражи се учесникФаза 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
Тражи се учесникОпсервациона студија
- Columbia University Irving Medical Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Тражи се учесник
- Lenox Hill Brain Tumor Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Тражи се учесникФаза 1/2
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Тражи се учесникФаза 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Тражи се учесникФаза 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Тражи се учесник
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Тражи се учесникФаза 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Тражи се учесникФаза 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
Studije za Мозгове туморске промене u drugim gradovima
- Houston, TX37 студија
- Boston, MA29 студија
- Washington, DC21 студија
- Los Angeles, CA17 студија
- Durham, NC15 студија
- Miami, FL14 студија
- Chicago, IL12 студија
- Rochester, MN12 студија
- St. Louis, MO12 студија
- Cleveland, OH11 студија
- Columbus, OH11 студија
- Seattle, WA11 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.